Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Spider Veins

fluorodeoxyglucose f18 has been researched along with Spider Veins in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agarwal, N; Attie, KM; Bendell, JC; Blobe, GC; Condon, CH; Gordon, MS; Hurwitz, HI; Jones, SF; McClure, T; Mendelson, DS; Pearsall, AE; Sharma, S; Sherman, ML; Wilson, D; Yang, Y	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Spider Veins

Article	Year
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jan-15, Volume: 20, Issue:2 Topics: Activin Receptors, Type II; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin Fc Fragments; Ligands; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Recombinant Fusion Proteins; Telangiectasis; Treatment Outcome	2014

Article

Year

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jan-15, Volume: 20, Issue:2

Topics: Activin Receptors, Type II; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin Fc Fragments; Ligands; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Recombinant Fusion Proteins; Telangiectasis; Treatment Outcome

2014